Close Menu

360Dx

Compared with RT-PCR testing, Abbott's BinaxNow test had a sensitivity of 64 percent for samples from symptomatic people and nearly 36 percent for asymptomatic people.

SureScreen's test will be deployed in educational settings, as well as for the testing of National Health Service and care home staff.

The firm expects to receive a CE mark later this year for its RT-qPCR breast cancer recurrence assay, which characterizes epithelial CTCs by detecting cytokeratin-19 expression.

The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A.

The company said it had signed definitive agreements to sell $6.6 million of its American Depository Shares to undisclosed institutional investors.